61426 Federal Register / Vol. 73, No. 201 / Thursday, October 16, 2008 / Notices 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average burden 

per response (in 

hours) 

Total burden 

hours 

1. Screener Respondents ................................................................ 14,000 1 3/60 700 

2. Interview respondents ................................................................. 5,000 1 1.2 6,000 

Total .......................................................................................... ............................ ............................ ............................ 6,700 

Dated: October 3, 2008. 

Maryam I. Daneshvar, 

Acting Reports Clearance Officer, Office of 

the Chief Science Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E8–24561 Filed 10–15–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60 Day-08–0134] 

Proposed Data Collections Submitted 

for Public Comment and 

Recommendations 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. 

Alternatively, to obtain a copy of the 

data collection plans and instrument, 

call 404–639–5960 and send comments 

to Maryam I. Daneshvar, CDC Reports 

Clearance Officer, 1600 Clifton Road 

NE., MS–D74, Atlanta, Georgia 30333; 

comments may also be sent by e-mail to 

omb@cdc.gov. 

Comments are invited on (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have a 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of information technology. Written 

comments should be received within 60 

days of this notice. 

Proposed Project 

Foreign Quarantine Regulations (42 

CFR part 71) (OMB Control No. 0920– 

0134)—Revision—National Center for 

Preparedness, Detection, and Control of 

Infectious Diseases (NCPDCID), Centers 

for Disease Control and Prevention 

(CDC) 

Background and Brief Description 

Section 361 of the Public Health 

Service Act (42 U.S.C. 264) authorizes 

the Secretary of Health and Human 

Services (HHS) to make and enforce 

regulations necessary to prevent the 

introduction, transmission, or spread of 

communicable diseases from foreign 

countries into the United States. 

Legislation and the existing regulations 

governing foreign quarantine activities 

(42 CFR part 71) authorize quarantine 

officers and other personnel to inspect 

and undertake control measures with 

respect to conveyances, persons, and 

shipments of animals and etiologic 

agents entering the United States from 

foreign ports in order to protect the 

public health. 

Under foreign quarantine regulations, 

the master of a ship or commander of an 

airplane entering the United States from 

a foreign port is required by public 

health law to report certain illnesses 

among passengers (42 CFR 71.21(b)). 

CDC recently reviewed 42 CFR part 71 

and determined that five data collection 

requirements and one recordkeeping 

requirement had not been included in 

previous information collection request 

submissions. Thus, in this request to 

OMB, CDC is requesting approval for an 

additional 2,902 burden hours. 

The first additional data collection 

requirement is the designation of yellow 

fever vaccination clinics. Under 42 CFR 

71.3, the Director of CDC delegates to 

states the responsibility for designation 

of yellow fever vaccination clinics to 

states and territories. States and 

territories then designate the clinics, 

based on application by the facilities 

and presentation of evidence. Under the 

regulation, facilities must provide 

evidence of adequate facilities and 

professionally trained personnel for 

handling, storage, and administration of 

the vaccine. The designated center must 

also comply with any instruction issued 

by the CDC Director for handling, 

storage, and administration of the 

vaccine. CDC estimates that 

approximately 500 professional staff are 

added each year as a registered stamp 

holder for the International Certificate of 

Vaccination or Prophylaxis. The 

estimated time to gather records and 

apply to become a stamp holder is one 

hour. The additional burden for this 

provision is 500 hours. 

The second additional data collection 

requirement is found in 42 CFR 

71.55(c). This provision requires that 

the remains of a person who died of a 

communicable disease listed in 

§ 71.32(b) may not be brought back into 

a U.S. port unless the body is (a) 

Properly embalmed and placed in a 

hermetically sealed casket, (b) cremated, 

or (c) accompanied by a permit issued 

by the Director of CDC. CDC has 

determined that the issuance of a permit 

implies a data collection requirement. 

CDC estimates a maximum of 5 

respondents annually with an average 

burden of one hour per respondent, for 

an increase of 5 hours for this provision. 

The last three data collection 

requirements are found under § 71.56. 

CDC established this section by Interim 

Final Rule in 2003 (68 FR 62353). This 

section prohibits the importation of 

African rodents, or any rodents whose 

native habitat is Africa, or any products 

derived from such rodents. Those 

wishing to import such animals or 

products may apply to the Director of 

CDC for an exemption to this 

prohibition and may appeal the 

Director’s decision. Finally, an 

individual or company may appeal a 

CDC order causing an animal to be 

quarantined, re-exported or destroyed. 

These data collection requirements were 

originally approved by OMB under 

OMB Control No. 0920–0615. This 

approval expired July 31, 2004. 

Although CDC collected data from less 

than 9 respondents annually since the 

Interim Final Rule went into effect, CDC 

wishes to reinstate the data collection 

requirement following recent review of 

42 CFR 71. This reinstatement is for 22 

burden hours. 

Finally, § 71.21(c) requires reporting 

of the number of cases (including zero) 

of gastrointestinal illness in passengers 

and crew recorded in the ship’s medical 

log during the current cruise. CDC had 

already included the reporting 
Federal Register / Vol. 73, No. 201 / Thursday, October 16, 2008 / Notices 61427 

requirement in its information 

collection request, but had not included 

the recordkeeping requirement of the 

medical log. In addition, CDC is 

changing the requirement from 

reporting gastrointestinal illness to 

reporting all diseases of public health 

significance. This submission includes 

the medical log recordkeeping 

requirement, for an additional 2,375 

burden hours. 

Respondents include airline pilots, 

ships’ captains, importers, medical 

professionals, and travelers. The nature 

of the quarantine response dictates 

which forms are completed by whom. 

There are no costs to respondents 

except their time to complete the forms. 

ESTIMATE OF ANNUALIZED BURDEN HOURS

Citation Number of 

respondents 

Responses per 

respondent 

Average burden 

per respondent 

(in hours) 

Total burden 

(in hours) 

71.21 Radio report death/illness ................................................... 9,500 1 2/60 317 

71.21(c) Medical log ...................................................................... 9,500 1 15/60 2,375 

71.3 Designation of yellow fever vaccination centers ................... 500 1 1 500 

71.33(c) Report by person(s) in isolation or surveillance ............. 11 1 3/60 1 

71.35 Report of death/illness in port ............................................. 5 1 30/60 3 

Outbreak of public health significance ............................................ 2,700,000 1 5/60 225,000 

Reporting of ill passenger(s) ........................................................... 800 1 5/60 67 

71.51(b)(3) Admission of cats/dogs; death/illness ........................ 5 1 3/60 1 

71.51(d) Dogs/cats; certification of confinement, vaccination ....... 1,200 1 15/60 300 

71.52(d) Turtle importation permits ............................................... 10 1 30/60 5 

71.53(d) Importer registration—nonhuman primates .................... 40 1 10/60 67 

71.53(d) Recordkeeping ................................................................ 30 4 30/60 60 

71.55 Permit for dead body .......................................................... 5 1 1 5 

71.56(a)(ii) Request for exemption ............................................... 12 1 1 12 

71.56(a)(iii) Appeal ........................................................................ 5 1 1 5 

71.56(c) Appeal ............................................................................. 5 1 1 5 

Total .......................................................................................... ............................ ............................ ............................ 228,723 

Dated: October 1, 2008. 

Maryam I. Daneshvar, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. E8–24568 Filed 10–15–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee, (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned committee: 

Times and Dates: 

9 a.m.–5 p.m., November 13, 2008. 

9 a.m.–1 p.m., November 14, 2008. 

Place: The Washington Marriott, 1221 

22nd Street, NW., Washington, DC 20037. 

Status: Open to the public, limited only by 

the space available. 

Purpose: The Committee is charged with 

providing advice and guidance to the 

Secretary, the Assistant Secretary for Health, 

the Director, CDC, and the Director, National 

Center for Preparedness, Detection, and 

Control of Infectious Diseases (NCPDCID), 

regarding (1) The practice of hospital 

infection control; (2) Strategies for 

surveillance, prevention, and control of 

infections (e.g., nosocomial infections), 

antimicrobial resistance, and related events 

in settings where healthcare is provided; and 

(3) Periodic updating of guidelines and other 

policy statements regarding prevention of 

healthcare-associated infections and 

healthcare-related conditions. 

Matters To Be Discussed: The agenda will 

include a follow-up discussion of Health and 

Human Services Healthcare-Associated 

Infections Elimination Process, Urinary Tract 

Infections Guideline, and Norovirus 

Guideline. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Wendy Vance, HICPAC, Division of 

Healthcare Quality Promotion, NCPDCID, 

CDC, l600 Clifton Road, NE., Mailstop D–10, 

Atlanta, Georgia 30333 Telephone (404) 639– 

2891. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: October 7, 2008. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention (CDC). 

[FR Doc. E8–24563 Filed 10–15–08; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Injury Prevention 

and Control/ Initial Review Group, 

(NCIPC/IRG) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting of the 

aforementioned review group: 

Times and Dates: 

7 p.m.–8 p.m., November 18, 2008 (Open). 

7:45 a.m.–5 p.m., November 19, 2008 

(Closed). 

7:45 a.m.–5 p.m., November 20, 2008 

(Closed). 

7:45 a.m.–5 p.m., November 21, 2008 

(Closed). 

Place: The W Hotel, 3377 Peachtree Road, 

NE., Atlanta, Georgia 30326, Telephone: 

(678) 500–3181. 

Status: Portions of the meetings will be 

closed to the public in accordance with 

provisions set forth in Section 552b(c)(4) and 

(6), Title 5, U.S.C., and the Determination of 

the Director, Management Analysis and 

Services Office, CDC, pursuant to Section 

10(d) of Public Law 92–463. 

Purpose: This group is charged with 

providing advice and guidance to the 

Secretary, Department of Health and Human 

Services, and the Director, CDC, concerning 

the scientific and technical merit of grant and 

cooperative agreement applications received